Cause-specific death and risk factors of one-year mortality after implantable cardioverter-defibrillator implantation: a nationwide study.
暂无分享,去创建一个
C. Torp‐Pedersen | L. Køber | P. Weeke | L. Østergaard | U. Mogensen | M. Vinther | E. Fosbøl | J. Butt | B. Philbert | A. Yafasova | PETER K. Jacobsen | A. Alhakak | Lauge Østergaard
[1] C. Torp‐Pedersen,et al. Identification of Patients with New-Onset Heart Failure and Reduced Ejection Fraction in Danish Administrative Registers , 2020, Clinical epidemiology.
[2] M. Kamalesh,et al. One‐year mortality after implantable cardioverter‐defibrillator placement within the Veterans Affairs Health System , 2020, European journal of heart failure.
[3] E. Marcantonio,et al. One-Year Mortality After Dialysis Initiation Among Older Adults. , 2019, JAMA internal medicine.
[4] H. Putter,et al. Prophylactic Use of Implantable Cardioverter-Defibrillators in the Prevention of Sudden Cardiac Death in Dialysis Patients. , 2019, Circulation.
[5] G. Gislason,et al. Clinical outcome in patients with implantable cardioverter-defibrillator and cancer: a nationwide study , 2018, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.
[6] A. Brandes,et al. Age and Outcomes of Primary Prevention Implantable Cardioverter-Defibrillators in Patients With Nonischemic Systolic Heart Failure , 2017, Circulation.
[7] P. Austin,et al. Mortality Implications of Appropriate Implantable Cardioverter Defibrillator Therapy in Secondary Prevention Patients: Contrasting Mortality in Primary Prevention Patients From a Prospective Population‐Based Registry , 2017, Journal of the American Heart Association.
[8] R. Tilz,et al. Implantable cardioverter defibrillator use for primary prevention in ischaemic and non-ischaemic heart disease—indications in the post-DANISH trial era: results of the European Heart Rhythm Association survey , 2017, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.
[9] H. Bøtker,et al. Positive predictive value of cardiac examination, procedure and surgery codes in the Danish National Patient Registry: a population-based validation study , 2016, BMJ Open.
[10] Hans Eiskjær,et al. Defibrillator Implantation in Patients with Nonischemic Systolic Heart Failure. , 2016, The New England journal of medicine.
[11] Andrea Mazzanti,et al. 2015 ESC Guidelines for the Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death. , 2016, Revista espanola de cardiologia.
[12] Sigrun Alba Johannesdottir Schmidt,et al. The Danish National Patient Registry: a review of content, data quality, and research potential , 2015, Clinical epidemiology.
[13] H. Bøtker,et al. Thirteen-year nationwide trends in use of implantable cardioverter-defibrillators and subsequent long-term survival. , 2015, Heart rhythm.
[14] M. Turakhia,et al. A validated risk model for 1-year mortality after primary prevention implantable cardioverter defibrillator placement. , 2015, American heart journal.
[15] Yiyi Zhang,et al. Clinical and serum-based markers are associated with death within 1 year of de novo implant in primary prevention ICD recipients. , 2015, Heart rhythm.
[16] P. Kudenchuk,et al. Outcomes of implantable cardioverter-defibrillator use in patients with comorbidities: results from a combined analysis of 4 randomized clinical trials. , 2014, JACC. Heart failure.
[17] Henrik Toft Sørensen,et al. The Danish Civil Registration System as a tool in epidemiology , 2014, European Journal of Epidemiology.
[18] P. Weeke,et al. Mortality and appropriate and inappropriate therapy in patients with ischaemic heart disease and implanted cardioverter-defibrillators for primary prevention: data from the Danish ICD Register. , 2013, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.
[19] J. Healey,et al. Survival After Implantable Cardioverter-Defibrillator Implantation in the Elderly , 2013, Circulation.
[20] L. Køber,et al. Stroke and bleeding in atrial fibrillation with chronic kidney disease. , 2012, The New England journal of medicine.
[21] J. Hallas,et al. The Danish National Prescription Registry , 2011, Scandinavian journal of public health.
[22] K. Helweg-larsen. The Danish Register of Causes of Death , 2011, Scandinavian journal of public health.
[23] Vibeke Jensen,et al. Danish education registers , 2011, Scandinavian journal of public health.
[24] J. Svendsen,et al. Nationwide study of sudden cardiac death in persons aged 1-35 years. , 2011, European heart journal.
[25] Jeroen J. Bax,et al. Long-term follow-up of primary and secondary prevention implantable cardioverter defibrillator patients. , 2011, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.
[26] M. Link,et al. Predictors of Early Mortality in Patients Age 80 and Older Receiving Implantable Defibrillators , 2010, Pacing and clinical electrophysiology : PACE.
[27] K. Stein,et al. Predictors of early mortality in implantable cardioverter-defibrillator recipients , 2009, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.
[28] Deepak L. Bhatt,et al. Meta-analysis of mortality in dialysis patients with an implantable cardioverter defibrillator. , 2009, The American journal of cardiology.
[29] D. Mark,et al. Prognostic importance of defibrillator shocks in patients with heart failure. , 2008, The New England journal of medicine.
[30] M. Sweeney,et al. Appropriate and Inappropriate Ventricular Therapies, Quality of Life, and Mortality Among Primary and Secondary Prevention Implantable Cardioverter Defibrillator Patients: Results From the Pacing Fast VT REduces Shock ThErapies (PainFREE Rx II) Trial , 2005, Circulation.
[31] Douglas L Packer,et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. , 2005, The New England journal of medicine.
[32] K. Lee,et al. A randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter Unsustained Tachycardia Trial Investigators. , 1999, The New England journal of medicine.
[33] M. Keller,et al. A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. , 1997, The New England journal of medicine.
[34] A. Moss,et al. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators. , 1996, The New England journal of medicine.
[35] A. Baranchuk,et al. Increased Incidence of Ventricular Arrhythmias in Patients With Advanced Cancer and Implantable Cardioverter-Defibrillators. , 2017, JACC. Clinical electrophysiology.
[36] L. Jordaens,et al. Early mortality in prophylactic implantable cardioverter-defibrillator recipients: development and validation of a clinical risk score. , 2014, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.
[37] Biykem Bozkurt,et al. 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. , 2013, Circulation.
[38] D. Hodge,et al. Development and validation of a risk score to predict early mortality in recipients of implantable cardioverter-defibrillators. , 2012, Heart rhythm.
[39] Silvia G. Priori,et al. ACC/AHA/ESC 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death ACC/AHA TASK FORCE MEMBERS ESC COMMITTEE FOR PRACTICE GUIDELINES , 2006 .
[40] C. Mackenzie,et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. , 1987, Journal of chronic diseases.